Comparison of Topical Nanocolloidal Silver Formulation Use With Eosin 2% Solution in Management of Hard-To-Heal Ulcers in Patients With Pemphigus Vulgaris

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Comparison of Topical Nanocolloidal Silver Formulation Use With Eosin 2% Solution in Management of Hard-To-Heal Ulcers in Patients With Pemphigus Vulgaris Publisher Pubmed

Abedini R¹ ; Mahmoudi H¹ ; Kordestani S^{2, 3} ; Habib FN² ; Abyaneh M³ ; Rahemi H³

Source: Journal of Wound Care Published:2020

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Rituximab in Practice: Clinical Evaluation of Patients With Pemphigus After Rituximab Administration, Dermatologic Therapy (2021)

2. Intralesional Injection of Biosimilar Rituximab in Recalcitrant Mucocutaneous Lesions of Patients With Pemphigus Vulgaris: A Pilot Study, Dermatologic Therapy (2020)

3. Pemphigus Disease and Area Index: Unmet Needs in the Real-World Management of Pemphigus, Oral Diseases (2023)

Experts (# of related papers)

View all Related Experts

Maryam Daneshpajooh (20)

Hamid Reza Mahmoodi (16)

Other Related Docs

4. Efficacy and Safety of Biosimilar Rituximab in Patients With Pemphigus Vulgaris: A Prospective Observational Study, Journal of Dermatological Treatment (2021)

5. Iranian Guideline for Rituximab Therapy in Pemphigus Patients, Dermatologic Therapy (2019)

6. Burden of Pemphigus Vulgaris With a Particular Focus on Women: A Review, International Journal of Women's Dermatology (2022)

7. Retrospective Study of Gingival Involvement in Pemphigus: A Difficult to Treat Phenomenon, Dermatologic Therapy (2022)

8. Applicability of Glucocorticoid Toxicity Index in Pemphigus: Comparison Between Two Groups of Rituximab-Treated and Rituximab-Naive Patients, Dermatologic Therapy (2022)

9. Rituximab Monotherapy in Mild Pemphigus, Journal of Dermatological Treatment (2022)

10. Evaluating the Risk-To-Benefit Ratio of Using Cotrimoxazole As a Pneumocystis Pneumonia Preventative Intervention Among Pemphigus Patients Treated With Rituximab: A Retrospective Study With 494 Patients, Dermatologic Therapy (2022)

11. Pemphigus Patients With Initial Negative Levels of Anti-Desmoglein: A Subtype With Different Profile?, Dermatologic Therapy (2022)

12. Assessing Quality of Life in Patients With Autoimmune Bullous Diseases Using the Persian Version of Treatment of Autoimmune Bullous Disease Quality of Life Questionnaire Finds Similar Effects in Women As Men, International Journal of Women's Dermatology (2022)

13. Current Status and Prospects for the Diagnosis of Pemphigus Vulgaris, Expert Review of Clinical Immunology (2021)

14. Covid-19: The Experience From Iran, Clinics in Dermatology (2021)

15. Paradoxical Reaction to Rituximab in Patients With Pemphigus: A Report of 10 Cases, Immunopharmacology and Immunotoxicology (2020)

16. Factors Associated With the Healing Time of Pemphigus Vulgaris Oral Lesions: A Prospective Study, Oral Diseases (2023)

17. Short-Term Clinical and Serological Follow-Up With Conventional and Conformational Anti-Desmoglein Antibodies in Treatment-Naive and Previously Treated Patients With Pemphigus Vulgaris After Receiving Rituximab, International Journal of Women's Dermatology (2019)

18. Updated S2k Guidelines on the Management of Pemphigus Vulgaris and Foliaceus Initiated by the European Academy of Dermatology and Venereology (Eadv), Journal of the European Academy of Dermatology and Venereology (2020)

19. Desquamative Gingivitis in a Pemphigus Vulgaris Patient Resistant to Rituximab, Dermatologic Therapy (2020)

20. Investigating Expression Pattern of Eight Immune-Related Genes in Pemphigus Patients Compared With the Healthy Controls and After Rituximab Therapy: Potential Roles of Ctla4 and Fcgr3a Genes Expression in Outcomes of Rituximab Therapy, Dermatologic Therapy (2020)

Style	Citing Format
MLA	Abedini R, et al.. "Comparison of Topical Nanocolloidal Silver Formulation Use With Eosin 2% Solution in Management of Hard-To-Heal Ulcers in Patients With Pemphigus Vulgaris." Journal of Wound Care, vol. 29, no. 11, 2020, pp. 664-668.
APA	Abedini R, Mahmoudi H, Kordestani S, Habib FN, Abyaneh M, Rahemi H (2020). Comparison of Topical Nanocolloidal Silver Formulation Use With Eosin 2% Solution in Management of Hard-To-Heal Ulcers in Patients With Pemphigus Vulgaris. Journal of Wound Care, 29(11), 664-668.
Chicago	Abedini R, Mahmoudi H, Kordestani S, Habib FN, Abyaneh M, Rahemi H. "Comparison of Topical Nanocolloidal Silver Formulation Use With Eosin 2% Solution in Management of Hard-To-Heal Ulcers in Patients With Pemphigus Vulgaris." Journal of Wound Care 29, no. 11 (2020): 664-668.
Harvard	Abedini R et al. (2020) 'Comparison of Topical Nanocolloidal Silver Formulation Use With Eosin 2% Solution in Management of Hard-To-Heal Ulcers in Patients With Pemphigus Vulgaris', Journal of Wound Care, 29(11), pp. 664-668.
Vancouver	Abedini R, Mahmoudi H, Kordestani S, Habib FN, Abyaneh M, Rahemi H. Comparison of Topical Nanocolloidal Silver Formulation Use With Eosin 2% Solution in Management of Hard-To-Heal Ulcers in Patients With Pemphigus Vulgaris. Journal of Wound Care. 2020;29(11):664-668.
BibTex	@article{ author = {Abedini R and Mahmoudi H and Kordestani S and Habib FN and Abyaneh M and Rahemi H}, title = {Comparison of Topical Nanocolloidal Silver Formulation Use With Eosin 2% Solution in Management of Hard-To-Heal Ulcers in Patients With Pemphigus Vulgaris}, journal = {Journal of Wound Care}, volume = {29}, number = {11}, pages = {664-668}, year = {2020} }
RIS	TY - JOUR AU - Abedini R AU - Mahmoudi H AU - Kordestani S AU - Habib FN AU - Abyaneh M AU - Rahemi H TI - Comparison of Topical Nanocolloidal Silver Formulation Use With Eosin 2% Solution in Management of Hard-To-Heal Ulcers in Patients With Pemphigus Vulgaris JO - Journal of Wound Care VL - 29 IS - 11 SP - 664 EP - 668 PY - 2020 ER -